Precision Medicine and Health Consortium (PMHC)

The Precision Medicine and Health Consortium capitalizes on the expertise within the scientific community, health systems, payor industry and others to make novel discoveries and therapeutic advances in precision medicine, and translate these to improve healthcare. 

The PMHC joins together faculty with a common purpose and connects faculty with expertise in precision medicine to address health problems using an interdisciplinary approach. It is our belief that a interdisciplinary group will more quickly advance research, educational, and outreach activities.

Members of the PMHC also bridge the gap between genetic research discoveries and application in patient care. Precision Medicine is a national priority and this group strives to keep on the forefront of this evolving field.

Latest News

The 2nd annual Summit on Precision Medicine was a success

Precision Medicine in Native American and Rural Health

Apr. 3, 2018

The 2nd annual Summit on Precision Medicine held on March 22, 2018 on the Duluth campus was a success.  This year the focus of the summit was on Precision Medicine in Native American and Rural Health.   

Pharmacogenomic Project on Sedation in Intubated Patients Receives Internal Funding

A College of Pharmacy internal grant has been awarded to the project, "Enhance Comprehensive Pharmacist Services to Improve Patient Health: Creating a 21 st Century Precision Medicine Intensive Care Unit (ICU)."

The focus of the project is on sedation in intubated patients and it aims to identify actionable genetic variants in ICU patients and evaluate the relationship between genotypes and drug efficacy as well as adverse drug reactions (ADR) in a real-world setting at the bedside.

NCI announced funding of a U54 grant project "Overcoming Drug Resistance in Multiple Myeloma"

As part of the Moonshot Initiative, NCI has announced the funding of a U54 grant with interactive projects to the University of Minnesota and Mayo Clinic.

The grant is entitled “Overcoming Drug Resistance in Multiple Myeloma”.  The project from the University of Minnesota is led by Dr. Brian Van Ness.

Precision Medicine Themed Issue of Pharmacotherapy Published

A Precison Medicine themed issue of Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy was published Sept. 20th, 2017.  The issue was edited by Jeffrey R. Bishop an Vicki L. Ellingrod.  Read the issue

Initial Protocol Released for "All of Us" Research Program

The NIH released the initial research protocol for the All of Us Research Program. Read the full announcement and the frequently asked questions releases.  

Seminar: Working Together on Pharmacogenetics: Report on a Tribal-University Partnership

Wylie BurkeWylie Burke, M.D., Ph.D.

Wednesday, April 12, 2017
"Working Together on Pharmacogenetics: Report on a Tribal-University Partnership"

The Precision Medicine and Health Disparities Summit

DNAThe Precision Medicine and Health Disparities Summit was held on Monday, March 27, 2017 at the University of Minnesota Medical School in Duluth.  See the recording of the event (x500 required).

Fairview Health Services: Can Genetic Tests Improve High Blood Pressure Care?

High blood pressureFairview Health Services is working with a local genetics research firm to determine if DNA tests can steer patients to more effective treatment for high blood pressure.

Pages

Pharmacogenomics Conference

Genomic Testing to Individualize Drug Therapy

Register Now!
June 22, 2018  -  7am-5pm
McNamara Alumni Center
University of Minnesota

Upcoming Seminars

Presented by The Minnesota Precision Medicine Collaborative

APRIL 6, 2018
Cardiovascular Epigenomics: From Chromatin Fiber to Human Populations

Thomas M. Vondriska, PhD
Professor of Anesthesiology, Medicine and
Physiology, David Geffen School of Medicine at UCLA

2:00 PM | 5-125 Moos Tower (TC); 302 Heller Hall (Duluth via ITV)

Join our Google Group

Join our Google Group to receive Precision Medicine and Health Consortium communications.

21st Century Cures Initiative Passed

Congress passed the 21st Century Cures Initiative, a $6.3 billion medical research bill. The bill authorizes significant funding for various health care related programs over the next 10 years, including $1.5 billion for Obama's Precision Medicine Initiative.

Links

2016 Precision Medicine Conference presentation videos

Genomics and Health Impact Weekly Scan  This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.

Contact Us

Pamala Jacobson, PharmD
pmhconso@umn.edu